These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36105584)
1. Heterotypic cell-in-cell structures between cancer and NK cells are associated with enhanced anticancer drug resistance. Choe YJ; Min JY; Lee H; Lee SY; Kwon J; Kim HJ; Lee J; Kim HM; Park HS; Cho MY; Hyun JY; Kim HM; Chung YH; Ha SK; Jeong HG; Choi I; Kim TD; Hong KS; Han EH iScience; 2022 Sep; 25(9):105017. PubMed ID: 36105584 [TBL] [Abstract][Full Text] [Related]
2. Heterotypic cell-in-cell structures in colon cancer can be regulated by IL-6 and lead to tumor immune escape. Wang S; Li L; Zhou Y; He Y; Wei Y; Tao A Exp Cell Res; 2019 Sep; 382(1):111447. PubMed ID: 31150612 [TBL] [Abstract][Full Text] [Related]
3. Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. Liu X; Yang J Front Oncol; 2023; 13():1242725. PubMed ID: 37637068 [TBL] [Abstract][Full Text] [Related]
4. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327 [TBL] [Abstract][Full Text] [Related]
6. Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer. Zhang X; Niu Z; Qin H; Fan J; Wang M; Zhang B; Zheng Y; Gao L; Chen Z; Tai Y; Yang M; Huang H; Sun Q Front Oncol; 2019; 9():895. PubMed ID: 31681557 [TBL] [Abstract][Full Text] [Related]
7. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4. Volonté A; Di Tomaso T; Spinelli M; Todaro M; Sanvito F; Albarello L; Bissolati M; Ghirardelli L; Orsenigo E; Ferrone S; Doglioni C; Stassi G; Dellabona P; Staudacher C; Parmiani G; Maccalli C J Immunol; 2014 Jan; 192(1):523-32. PubMed ID: 24277698 [TBL] [Abstract][Full Text] [Related]
9. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Su Y; Huang H; Luo T; Zheng Y; Fan J; Ren H; Tang M; Niu Z; Wang C; Wang Y; Zhang Z; Liang J; Ruan B; Gao L; Chen Z; Melino G; Wang X; Sun Q Cell Discov; 2022 Apr; 8(1):35. PubMed ID: 35436988 [TBL] [Abstract][Full Text] [Related]
10. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells. Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746 [TBL] [Abstract][Full Text] [Related]
11. Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas. Schenker H; Büttner-Herold M; Fietkau R; Distel LV Radiat Oncol; 2017 Jan; 12(1):21. PubMed ID: 28100275 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy. Chen YH; Wang S; He MF; Wang Y; Zhao H; Zhu HY; Yu XM; Ma J; Che XJ; Wang JF; Wang Y; Wang XN PLoS One; 2013; 8(3):e59418. PubMed ID: 23555668 [TBL] [Abstract][Full Text] [Related]
13. AIM-CICs: an automatic identification method for cell-in-cell structures based on convolutional neural network. Tang M; Su Y; Zhao W; Niu Z; Ruan B; Li Q; Zheng Y; Wang C; Zhang B; Zhou F; Wang X; Huang H; Shi H; Sun Q J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35869978 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence-Activated Cell Sorting Analysis of Heterotypic Cell-in-Cell Structures. He M; Huang H; Wang M; Chen A; Ning X; Yu K; Li Q; Li W; Ma L; Chen Z; Wang X; Sun Q Sci Rep; 2015 Apr; 5():9588. PubMed ID: 25913618 [TBL] [Abstract][Full Text] [Related]
15. Classification of Cell-in-Cell Structures: Different Phenomena with Similar Appearance. Borensztejn K; Tyrna P; Gaweł AM; Dziuba I; Wojcik C; Bialy LP; Mlynarczuk-Bialy I Cells; 2021 Sep; 10(10):. PubMed ID: 34685548 [TBL] [Abstract][Full Text] [Related]
16. Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies. Okuyama K; Fukushima H; Naruse T; Yanamoto S Front Oncol; 2023; 13():1248097. PubMed ID: 37790755 [TBL] [Abstract][Full Text] [Related]
17. L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer. Chen J; Gao F; Liu N Exp Ther Med; 2018 Mar; 15(3):2792-2797. PubMed ID: 29456682 [TBL] [Abstract][Full Text] [Related]
18. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids. Chen YA; Lu CY; Cheng WF; Kuo KT; Yu CW; Ho HN; Chen HF; Pan SH BMC Cancer; 2022 Sep; 22(1):967. PubMed ID: 36085021 [TBL] [Abstract][Full Text] [Related]
19. Targeting the cancer initiating cell: the ultimate target for cancer therapy. McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167 [TBL] [Abstract][Full Text] [Related]